Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1986 Apr;29(4):543–548. doi: 10.1128/aac.29.4.543

Aminoglycoside research 1975-1985: prospects for development of improved agents.

K E Price
PMCID: PMC180438  PMID: 3518623

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews R. J., Brammer K. W., Cheeseman H. E., Jevons S. UK-18,892: resistance to modification by aminoglycoside-inactivating enzymes. Antimicrob Agents Chemother. 1978 Dec;14(6):846–850. doi: 10.1128/aac.14.6.846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Betts R. F., Valenti W. M., Chapman S. W., Chonmaitree T., Mowrer G., Pincus P., Messner M., Robertson R. Five-year surveillance of aminoglycoside usage in a university hospital. Ann Intern Med. 1984 Feb;100(2):219–222. doi: 10.7326/0003-4819-100-2-219. [DOI] [PubMed] [Google Scholar]
  3. Bock B. V., Edelstein P. H., Meyer R. D. Prospective comparative study of efficacy and toxicity of netilmicin and amikacin. Antimicrob Agents Chemother. 1980 Feb;17(2):217–225. doi: 10.1128/aac.17.2.217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Came P. E., O'Connor J. R., Dobson R. A., Wagner R. B., Fabian R. J. Antibacterial activities, nephrotoxicity, and ototoxicity of a new aminoglycoside, Win 42122-2. Antimicrob Agents Chemother. 1979 Dec;16(6):813–822. doi: 10.1128/aac.16.6.813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Daniels P. J., Luce C., Nagabhushan T. L. The gentamicin antibiotics. 6. Gentamicin C2b, an aminoglycoside antibiotic produced by Micromonospora purpurea mutant JI-33. J Antibiot (Tokyo) 1975 Jan;28(1):35–41. doi: 10.7164/antibiotics.28.35. [DOI] [PubMed] [Google Scholar]
  6. Daum S. J., Rosi D., Goss W. A. Mutational biosynthesis by idiotrophs of Micromonospora purpurea. II. Conversion of non-amino containing cyclitols to aminoglycoside antibiotics. J Antibiot (Tokyo) 1977 Jan;30(1):98–105. doi: 10.7164/antibiotics.30.98. [DOI] [PubMed] [Google Scholar]
  7. Girolami R. L., Stamm J. M. Comparative antimicrobial activity of O-demethylfortimicin A, a derivative of fortimicin A. Antimicrob Agents Chemother. 1980 Nov;18(5):766–772. doi: 10.1128/aac.18.5.766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hottendorf G. H., Barnett D., Gordon L. L., Christensen E. F., Madissoo H. Nonparallel nephrotoxicity dose-response curves of aminoglycosides. Antimicrob Agents Chemother. 1981 Jun;19(6):1024–1028. doi: 10.1128/aac.19.6.1024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hottendorf G. H., Gordon L. L. Comparative low-dose nephrotoxicities of gentamicin, tobramycin, and amikacin. Antimicrob Agents Chemother. 1980 Jul;18(1):176–181. doi: 10.1128/aac.18.1.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jones R. N., Thornsberry C., Barry A. L., Packer R. R., Baker C. N., Badal R. E. Compound A49759, the 3-O-demethyl derivative of fortimicin A: in vitro comparison with six other aminoglycoside antibiotics. Antimicrob Agents Chemother. 1980 Nov;18(5):773–779. doi: 10.1128/aac.18.5.773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kawaguchi H., Naito T., Nakagawa S., Fujisawa K. I. BB-K 8, a new semisynthetic aminoglycoside antibiotic. J Antibiot (Tokyo) 1972 Dec;25(12):695–708. doi: 10.7164/antibiotics.25.695. [DOI] [PubMed] [Google Scholar]
  12. Kimura E. T., Tekeli S., Lewkowski J. P., Majors K. R., Kesterson J. W. Acute and subacute toxicity studies with fortimicin A sulfate (Abbott-44747), a new aminoglycoside antibiotic. Toxicol Appl Pharmacol. 1980 May;53(3):399–409. doi: 10.1016/0041-008x(80)90353-1. [DOI] [PubMed] [Google Scholar]
  13. Kimura E. T., Tekeli S., Pratt M. C., Kesterson J. W., Cusick P. K., Heyman I. A., Majors K. R. Acute, subchronic, and chronic toxicity studies with 3-O-demethylfortimicin A disulfate, a new aminocyclitol antibiotic. Toxicol Appl Pharmacol. 1985 Aug;80(1):66–77. doi: 10.1016/0041-008x(85)90102-4. [DOI] [PubMed] [Google Scholar]
  14. Koch K. F., Rhoades J. A. Structure of nebramycin factor 6, a new aminoglycosidic antibiotic. Antimicrob Agents Chemother (Bethesda) 1970;10:309–313. [PubMed] [Google Scholar]
  15. Kondo S., Iinuma K., Yamamoto H., Maeda K., Umezawa H. Letter: Syntheses of 1-n-(S)-4-amino-2-hydroxybutyryl)-kanamycin B and -3', 4'-dideoxykanamycin B active against kanamycin-resistant bacteria. J Antibiot (Tokyo) 1973 Jul;26(7):412–415. doi: 10.7164/antibiotics.26.412. [DOI] [PubMed] [Google Scholar]
  16. Luft F. C. Netilmicin: a review of toxicity in laboratory animals. J Int Med Res. 1978;6(4):286–299. doi: 10.1177/030006057800600406. [DOI] [PubMed] [Google Scholar]
  17. Miller G. H., Arcieri G., Weinstein M. J., Waitz J. A. Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic. Antimicrob Agents Chemother. 1976 Nov;10(5):827–836. doi: 10.1128/aac.10.5.827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Miller G. H., Chiu P. J., Waitz J. A. Biological activity of SCH 21420, the 1-N-S-alpha-hydroxy-beta-aminopropionyl derivative of gentamicin B. J Antibiot (Tokyo) 1978 Jul;31(7):688–696. doi: 10.7164/antibiotics.31.688. [DOI] [PubMed] [Google Scholar]
  19. Moody M. M., de Jongh C. A., Schimpff S. C., Tillman G. L. Long-term amikacin use. Effects on aminoglycoside susceptibility patterns of gram-negative bacilli. JAMA. 1982 Sep 10;248(10):1199–1202. doi: 10.1001/jama.248.10.1199. [DOI] [PubMed] [Google Scholar]
  20. Nagabhushan T. L., Cooper A. B., Tsai H., Daniels P. J., Miller G. H. The syntheses and biological properties of 1-N-(S-4-amino-2-hydroxybutyryl)-gentamicin B and 1-N-(S-3-amino-2-hydroxypropionyl)-gentamicin B. J Antibiot (Tokyo) 1978 Jul;31(7):681–687. doi: 10.7164/antibiotics.31.681. [DOI] [PubMed] [Google Scholar]
  21. Naito T., Nakagawa S., Toda S., Fujisawa K., Kawaguchi H. Aminoglycoside antibiotics. XIII. Synthesis and activity of 4-deoxy-6'-n-methylamikacin and related compounds. J Antibiot (Tokyo) 1979 Jun;32(6):659–664. doi: 10.7164/antibiotics.32.659. [DOI] [PubMed] [Google Scholar]
  22. Nara T., Yamamoto M., Kawamoto I., Takayama K., Okachi R., Takasawa S., Sato T., Sato S. Fortimicins A and B, new aminoglycoside antibiotics. I. Producing organism, fermentation and biological properties of fortimicins. J Antibiot (Tokyo) 1977 Jul;30(7):533–540. doi: 10.7164/antibiotics.30.533. [DOI] [PubMed] [Google Scholar]
  23. Neu H. C., Fu K. P. 1-N HAPA gentamicin B, a new aminoglycoside active against gentamicin resistant isolates--activity compared to other aminoglycosides. J Antibiot (Tokyo) 1978 May;31(5):385–393. doi: 10.7164/antibiotics.31.385. [DOI] [PubMed] [Google Scholar]
  24. Okachi R., Kawamoto I., Takasawa S., Yamamoto M., Sato S. A new antibiotic XK-62-2 (Sagamicin). I. Isolation, physicochemical and antibacterial properties. J Antibiot (Tokyo) 1974 Oct;27(10):793–800. doi: 10.7164/antibiotics.27.793. [DOI] [PubMed] [Google Scholar]
  25. Parker R. A., Gilbert D. N., Houghton D. C., Porter G. A., Bennett W. M. Comparative nephrotoxicities of high-dose netilmicin and tobramycin in rats. Antimicrob Agents Chemother. 1980 Aug;18(2):346–348. doi: 10.1128/aac.18.2.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Price K. E., Chisholm D. R., Misiek M., Leitner F., Tsai Y. H. Microbiological evaluation of BB-K 8, a new semisynthetic aminoglycoside. J Antibiot (Tokyo) 1972 Dec;25(12):709–731. doi: 10.7164/antibiotics.25.709. [DOI] [PubMed] [Google Scholar]
  27. Richardson K., Brammer K. W., Jevons S., Plews R. M., Wright J. R. Synthesis and antibacterial activity of 1-N-(1,3-dihydroxy-2-propyl)kanamycin B (UK-31,214). J Antibiot (Tokyo) 1979 Oct;32(10):973–977. doi: 10.7164/antibiotics.32.973. [DOI] [PubMed] [Google Scholar]
  28. Richardson K., Jevons S., Moore J. W., Ross B. C., Wright J. R. Synthesis and antibacterial activities of 1-N [(S)-omega-amino-2-hydroxyalkyl] kanamycin A derivatives. J Antibiot (Tokyo) 1977 Oct;30(10):843–846. doi: 10.7164/antibiotics.30.843. [DOI] [PubMed] [Google Scholar]
  29. Rosi D., Goss W. A., Daum S. J. Mutational biosynthesis by idiotrophs of Micromonospora purpurea. I. Conversion of aminocyclitols to new aminoglycoside antibiotics. J Antibiot (Tokyo) 1977 Jan;30(1):88–97. doi: 10.7164/antibiotics.30.88. [DOI] [PubMed] [Google Scholar]
  30. UMEZAWA H., UEDA M., MAEDA K., YAGISHITA K., KONDO S., OKAMI Y., UTAHARA R., OSATO Y., NITTA K., TAKEUCHI T. Production and isolation of a new antibiotic: kanamycin. J Antibiot (Tokyo) 1957 Sep;10(5):181–188. [PubMed] [Google Scholar]
  31. Umezawa H., Umezawa S., Tsuchiya T., Okazaki Y. 3',4'-dideoxy-kanamycin B active against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa. J Antibiot (Tokyo) 1971 Jul;24(7):485–487. doi: 10.7164/antibiotics.24.485. [DOI] [PubMed] [Google Scholar]
  32. WEINSTEIN M. J., LUEDEMANN G. M., ODEN E. M., WAGMAN G. H., ROSSELET J. P., MARQUEZ J. A., CONIGLIO C. T., CHARNEY W., HERZOG H. L., BLACK J. GENTAMICIN, A NEW ANTIBIOTIC COMPLEX FROM MICROMONOSPORA. J Med Chem. 1963 Jul;6:463–464. doi: 10.1021/jm00340a034. [DOI] [PubMed] [Google Scholar]
  33. Waitz J. A., Miller G. H., Moss E., Jr, Chiu P. J. Chemotherapeutic evaluation of 5-episisomicin (Sch 22591), a new semisynthetic aminoglycoside. Antimicrob Agents Chemother. 1978 Jan;13(1):41–48. doi: 10.1128/aac.13.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Weinstein M. J., Marquez J. A., Testa R. T., Wagman G. H., Oden E. M., Waitz J. A. Antibiotic 6640, a new Micromonospora-produced aminoglycoside antibiotic. J Antibiot (Tokyo) 1970 Nov;23(11):551–554. doi: 10.7164/antibiotics.23.551. [DOI] [PubMed] [Google Scholar]
  35. Weinstein M. J., Wagman G. H., Marquez J. A., Testa R. T., Waitz J. A. Verdamicin, a new broad spectrum aminoglycoside antibiotic. Antimicrob Agents Chemother. 1975 Mar;7(3):246–249. doi: 10.1128/aac.7.3.246. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES